Andere Sprachen DarioHealth Corp.

Aktien

A2PU1R

US23725P2092

DRIO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
1,48 ^USD	+0,68 %		+27,59 %	-13,95 %

25.04.	DarioHealth Corp. veröffentlicht neue, von Fachleuten begutachtete Studie, die den Beweis erbringt, dass die Verwaltung kardiometabolischer Erkrankungen auf einer integrierten Plattform die klinischen Ergebnisse verbessert	CI
18.04.	DarioHealth Corp. unterzeichnet zwei Verträge mit Arbeitgebern für die Cardiometabolic Suite mit integrierter Glp-1 Lösung	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25.04.
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25.04.
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution	18.04.
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	18.04.
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10.04.
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10.04.
TWO NATIONAL EMPLOYERS SELECT DARIO S INTEGRATED CHRONIC CONDITION SOLUTION TO IMPROVE EMPLOYEE HEALTH	03.04.
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health	02.04.
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	02.04.
DarioHealth : Q4 and full year 2023 earnings call transcript	01.04.
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results	28.03.
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
North American Morning Briefing : Stocks Set for -2-	28.03.
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH	21.03.
North American Morning Briefing : Investors -2-	21.03.
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications	12.03.
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	12.03.
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE	28.02.
DarioHealth Corp. Appoints Tomer Ben-Kiki as Chief Operating Officer	21.02.
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions	21.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen DarioHealth Corp.

Aktien

A2PU1R

US23725P2092

DRIO

Andere Sprachen

Filter